Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationshipsJournal of antimicrobial chemotherapy, 2017-10, Vol.72 (10), p.2891-2897 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkx209 ;PMID: 29091190Full text available |
|
2 |
Material Type: Article
|
Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and CefepimeClinical infectious diseases, 2017-01, Vol.64 (2), p.116-123 [Peer Reviewed Journal]Copyright © 2017 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciw709 ;PMID: 27986669Full text available |
|
3 |
Material Type: Article
|
Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?Clinical infectious diseases, 2020-07, Vol.71 (2), p.426-432 [Peer Reviewed Journal]The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2019 ;The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciz1189 ;PMID: 31833540Full text available |
|
4 |
Material Type: Article
|
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysisClinical infectious diseases, 2013-01, Vol.56 (2), p.272-282 [Peer Reviewed Journal]Copyright © 2013 Oxford University Press on behalf of the Infectious Diseases Society of America ;2014 INIST-CNRS ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/cis857 ;PMID: 23074314 ;CODEN: CIDIELFull text available |
|
5 |
Material Type: Article
|
Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or CefepimeAntimicrobial agents and chemotherapy, 2017-02, Vol.61 (2) [Peer Reviewed Journal]Copyright © 2017 American Society for Microbiology. ;Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.02089-16 ;PMID: 27895019Full text available |
|
6 |
Material Type: Article
|
Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or CefepimeAntimicrobial agents and chemotherapy, 2022-08, Vol.66 (8), p.e0004022 [Peer Reviewed Journal]Copyright © 2022 American Society for Microbiology. ;Copyright © 2022 American Society for Microbiology. 2022 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.00040-22 ;PMID: 35867523Full text available |
|
7 |
Material Type: Article
|
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injuryJournal of antimicrobial chemotherapy, 2023-02, Vol.78 (2), p.478-487 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkac416 ;PMID: 36545869Full text available |
|
8 |
Material Type: Article
|
Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-TazobactamPharmacotherapy, 2014-07, Vol.34 (7), p.670-676 [Peer Reviewed Journal]2014 Pharmacotherapy Publications, Inc. ;2015 INIST-CNRS ;ISSN: 0277-0008 ;EISSN: 1875-9114 ;DOI: 10.1002/phar.1442 ;PMID: 24855041 ;CODEN: PHPYDQFull text available |
|
9 |
Material Type: Article
|
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamClinical infectious diseases, 2023-02, Vol.76 (3), p.e1444-e1455 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciac670 ;PMID: 35982631Full text available |
|
10 |
Material Type: Article
|
Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or CefepimePharmacotherapy, 2014-07, Vol.34 (7), p.662-669 [Peer Reviewed Journal]2014 Pharmacotherapy Publications, Inc. ;2015 INIST-CNRS ;ISSN: 0277-0008 ;EISSN: 1875-9114 ;DOI: 10.1002/phar.1428 ;PMID: 24753221 ;CODEN: PHPYDQFull text available |
|
11 |
Material Type: Article
|
Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort StudyPharmacotherapy, 2016-05, Vol.36 (5), p.463-471 [Peer Reviewed Journal]2016 Pharmacotherapy Publications, Inc. ;ISSN: 0277-0008 ;EISSN: 1875-9114 ;DOI: 10.1002/phar.1738 ;PMID: 26952639Full text available |
|
12 |
Material Type: Article
|
Using Japanese big data to investigate novel factors and their high‐risk combinations that affect vancomycin‐induced nephrotoxicityBritish journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3241-3255 [Peer Reviewed Journal]2022 British Pharmacological Society ;2022 British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.15252 ;PMID: 35106797Full text available |
|
13 |
Material Type: Article
|
Bloodstream infections in neutropenic cancer patients: A practical updateVirulence, 2016-04, Vol.7 (3), p.280-297 [Peer Reviewed Journal]2016 Taylor & Francis 2016 ;2016 Taylor & Francis 2016 Taylor & Francis ;ISSN: 2150-5594 ;EISSN: 2150-5608 ;DOI: 10.1080/21505594.2016.1156821 ;PMID: 27002635Full text available |
|
14 |
Material Type: Article
|
Piperacillin-tazobactam as the unusual cause of fever in a young male with an amoebic liver abscessIndian journal of pharmacology, 2024-03, Vol.56 (2), p.144-145 [Peer Reviewed Journal]EISSN: 1998-3751 ;DOI: 10.4103/ijp.ijp_603_23 ;PMID: 38687318Full text available |
|
15 |
Material Type: Article
|
Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysisPharmacotherapy, 2016-12, Vol.36 (12), p.1217-1228 [Peer Reviewed Journal]2016 Pharmacotherapy Publications, Inc. ;ISSN: 0277-0008 ;EISSN: 1875-9114 ;DOI: 10.1002/phar.1851 ;PMID: 27805728Full text available |
|
16 |
Material Type: Article
|
Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapyJournal of antimicrobial chemotherapy, 2021-01, Vol.76 (1), p.212-219 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. ;The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. 2020 ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkaa385 ;PMID: 32944771Full text available |
|
17 |
Material Type: Article
|
Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial StewardshipAntimicrobial agents and chemotherapy, 2016-06, Vol.60 (6), p.3743-3750 [Peer Reviewed Journal]Copyright © 2016, American Society for Microbiology. All Rights Reserved. ;Copyright © 2016, American Society for Microbiology. All Rights Reserved. 2016 American Society for Microbiology ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/AAC.03011-15 ;PMID: 27067325Full text available |
|
18 |
Material Type: Article
|
Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched studyJournal of critical care, 2022-02, Vol.67, p.134-140 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0883-9441 ;EISSN: 1557-8615 ;DOI: 10.1016/j.jcrc.2021.10.018 ;PMID: 34768175Full text available |
|
19 |
Material Type: Article
|
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysisPloS one, 2015-01, Vol.10 (1), p.e0116769-e0116769 [Peer Reviewed Journal]COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Yang et al 2015 Yang et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0116769 ;PMID: 25575030Full text available |
|
20 |
Material Type: Article
|
Antibiotic-induced black hairy tongue: two case reports and a review of the literatureJournal of international medical research, 2020-10, Vol.48 (10), p.300060520961279-300060520961279 [Peer Reviewed Journal]The Author(s) 2020 ;The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 SAGE Publications ;ISSN: 0300-0605 ;EISSN: 1473-2300 ;DOI: 10.1177/0300060520961279 ;PMID: 33044871Full text available |